Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-27

Clinical Trial Update: Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of Yi-Gan San in children and adolescents with Tourette's Disorder and tic disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yi-Gan San

Snippet

Sponsor: China Medical University Hospital | Conditions: Tourette Disorder, Tic Disorders | Phase 2 | Status: COMPLETED